Vivace Therapeutics
Drug DiscoveryWebsite
Operator of a small molecule drug discovery firm intended to introduce new treatments for cancer patients. The company creates therapies that target distinct biological pathways and function either al...
Valuation
$125M
Market implied
Share Price
N/A
Total Raised
$105M
Last Round
Later Stage VC (Series D)
Feb 2025
Latest Funding Round
Later Stage VC (Series D)
Feb 28, 2025
$35M
raised
Investors
+11 other investors